Z. Tan

Evaluation of BNT162b2 vaccine effectiveness in Malaysia: test negative case-control study

S. Sivasampu, K. Peariasamy, N. Ab Rahman, 2022, Vaccine.

Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma

Jiayong Liu, T. Gao, Z. Fan, 2021, Annals of translational medicine.

The efficacy of 99mTc-rituximab as a tracer for sentinel lymph node biopsy in cutaneous melanoma patients

T. Gao, Z. Fan, Z. Fang, 2022, Annals of translational medicine.

KIF18B promotes tumor progression in osteosarcoma by activating β-catenin

Jiayong Liu, Ling Yu, T. Gao, 2020, Cancer biology & medicine.

Clinical features and therapeutic outcomes of alveolar soft part sarcoma in children: A single-center, retrospective study

Xinyu Wang, T. Gao, Z. Fan, 2022, Frontiers in Oncology.

Target therapy for metastatic alveolar soft part sarcoma: a retrospective study with 47 cases

Jiayong Liu, T. Gao, Z. Fan, 2020, Annals of translational medicine.

Efficacy and safety of anlotinib plus TQB2450 in patients with advanced soft tissue sarcoma: A multicenter, single armed, phase 1b trial.

Lu Xie, Jie Xu, Jiayong Liu, 2021 .

Efficacy of PD-1 inhibitors combined with pegylated liposomal doxorubicin and dacarbazine compared with liposomal doxorubicin and dacarbazine in advanced leiomyosarcoma patients: a retrospective, single-institutional cohort study

Xinyu Wang, T. Gao, Z. Fan, 2022, Annals of Translational Medicine.

Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma

Lu Xie, Jie Xu, T. Gao, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Targeting MCM2 activates cancer-associated fibroblasts-like phenotype and affects chemo-resistance of liposarcoma cells against doxorubicin.

Z. Fan, Chu-jie Bai, Shu Li, 2024, Anti-cancer drugs.